Welcome!

News Feed Item

Global MicroRNA Market Report


DUBLIN, Apr. 15, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/6zn3pr/global_microrna

) has announced the addition of the

"Global MicroRNA Market Report"

report to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.



The report, Global MicroRNA Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.



A biomarker is a substance or a molecular or cellular process or event that indicates a biological condition. Several research studies have confirmed that

microRNAs

have immense potential as biomarkers for a range of diseases, from cancer to cardiovascular diseases. An increasing number of vendors in the market are focusing on the discovery of microRNA biomarkers for diseases that do not as yet have defined microRNA biomarkers.


For instance, Biogen Idec Inc., a US-based biotechnology company focusing on the development of drugs for the Healthcare sector, and Regulus Therapeutics Inc., a US-based microRNA therapeutics company, have collaborated in their efforts to discover and develop microRNA biomarkers for multiple sclerosis. Thus, the Global MicroRNA market is witnessing the increasing use of microRNAs as biomarkers.

According to the report, one of the most important drivers is the increasing prevalence of diseases such as cancer, which has led to an increase in demand for microRNA-based diagnostic tests.


Key Topics Covered:

01. Executive Summary

02. Scope of the Report

03. Market Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

07. Global MicroRNA Research Market

08. Global MicroRNA Market

09. Global MicroRNA Market Segmentation

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series


Companies Mentioned:

  • Access Pharmaceuticals
  • Aegera Therapeutics Inc.
  • Affymetrix Inc.
  • Agilent Technologies
  • Alnylam Pharmaceuticals Inc.
  • Antisense Pharma GmbH
  • Aparna Biosciences Corp.
  • Applied Biological Materials Inc.
  • Arrowhead Research Corp.
  • AstraZeneca Pharmaceuticals LP
  • Asuragen Inc.
  • Benitec Biopharma Ltd.
  • BioCancell Therapeutics Inc.
  • Biogen Idec Inc.
  • CBC Comprehensive Biomarker Center GmbH
  • Clontech Laboratories Inc.
  • Dicerna Pharmaceuticals Inc.
  • EMD4Biosciences
  • Eli Lilly and Co.
  • Exiqon A/S
  • Expression Genetics Inc.
  • F. Hoffman-La Roche AG
  • Fluidigm Corp.
  • GeneCopoeia Inc.
  • GenoSensor Corp.
  • Gensignia Inc.
  • GlaxoSmithKline
  • Groove Biopharma
  • HTG Molecular Diagnostics Inc.
  • Idera Pharmaceuticals Inc.
  • Illumina Inc.
  • InteRNA Technologies B.V.
  • Isis Pharmaceuticals Inc.
  • LC Sciences Llc
  • Life Technologies Corp.
  • Merck & Co. Inc.
  • Mirna Therapeutics Inc.
  • NanoString Technologies Inc.
  • Norgen Biotek Corp.
  • Novartis AG
  • Pfizer Inc.
  • Phalanx Biotech Group
  • PhaseRx Inc.
  • Prolias Technologies Inc.
  • Qiagen N.V.
  • Quark Pharmaceuticals Inc.
  • RXi Pharmaceuticals Corp.
  • Regulus Therapeutics Inc.
  • Rosetta Genomics Ltd.
  • Sanofi U.S.
  • Santaris Pharma A/S.
  • Sarepta Therapeutics
  • Sigma-Aldrich Co. Llc
  • Silence Therapeutics Plc
  • Sirnaomics Inc.
  • Sylentis SA
  • Tacere Therapeutics Inc.
  • Tekmira Pharmaceuticals Corp.
  • Theradiag
  • Thermo Fisher Scientific Inc.
  • WaferGen Biosystems Inc.
  • miRagen Therapeutics Inc.
  • siRNAsense AS

For more information visit http://www.researchandmarkets.com/research/6zn3pr/global_microrna

Media Contact: Laura Wood , +353-1-481-1716, [email protected]



 

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams. In his session at 22nd Cloud Expo | DXWorld Expo, Daniel Jones, CTO of EngineerBetter, will answer: How can we improve willpower and decrease technical debt? Is the present bias real? How can we turn it to our advantage? Can you increase a team’s effective IQ? How do DevOps & Product Teams increase empathy, and what impact does empath...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
"Digital transformation - what we knew about it in the past has been redefined. Automation is going to play such a huge role in that because the culture, the technology, and the business operations are being shifted now," stated Brian Boeggeman, VP of Alliances & Partnerships at Ayehu, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
You know you need the cloud, but you're hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You're looking at private cloud solutions based on hyperconverged infrastructure, but you're concerned with the limits inherent in those technologies. What do you do?
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
"We started a Master of Science in business analytics - that's the hot topic. We serve the business community around San Francisco so we educate the working professionals and this is where they all want to be," explained Judy Lee, Associate Professor and Department Chair at Golden Gate University, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
The 22nd International Cloud Expo | 1st DXWorld Expo has announced that its Call for Papers is open. Cloud Expo | DXWorld Expo, to be held June 5-7, 2018, at the Javits Center in New York, NY, brings together Cloud Computing, Digital Transformation, Big Data, Internet of Things, DevOps, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...